 |
answer text |
<p>Avastin has approval from the European Medicines Agency to be used to treat cancer
in combination with specific chemotherapies in the advanced stages of several cancers.
They are:</p><p>- Metastatic colorectal cancer;</p><p>- Metastatic breast cancer;</p><p>-
Certain types of unresectable advanced, metastatic or recurrent lung cancer;</p><p>-
Advanced or metastatic renal cell cancer;</p><p>- Advanced or recurrent or resistant
ovarian/fallopian tube cancer; and</p><p>- Persistent or recurrent or metastatic cervical
cancer.</p><p>Full details of the indications that Avastin is licensed for can be
found in the European public assessment report for Avastin. It explains how the Agency
assessed the medicine to recommend its authorisation and its conditions of use and
is publicly available on their website.</p>
|
 |
